scholarly journals Phase I study of tivantinib in Japanese patients with advanced hepatocellular carcinoma: Distinctive pharmacokinetic profiles from other solid tumors

2015 ◽  
Vol 106 (5) ◽  
pp. 611-617 ◽  
Author(s):  
Takuji Okusaka ◽  
Takeshi Aramaki ◽  
Yoshitaka Inaba ◽  
Shinichiro Nakamura ◽  
Manabu Morimoto ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients ◽  
Advanced Hepatocellular Carcinoma ◽  
Pharmacokinetic Profiles

scholarly journals Phase I study of TAC-101, an oral synthetic retinoid, in Japanese patients with advanced hepatocellular carcinoma

2012 ◽  
Vol 103 (8) ◽  
pp. 1524-1530 ◽  
Author(s):  
Takuji Okusaka ◽  
Hideki Ueno ◽  
Masafumi Ikeda ◽  
Yoriko Takezako ◽  
Chigusa Morizane
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase I ◽  
Phase I Study ◽  
Japanese Patients ◽  
Advanced Hepatocellular Carcinoma ◽  
Synthetic Retinoid

scholarly journals Phase I study of nintedanib in Japanese patients with advanced hepatocellular carcinoma and liver impairment

2016 ◽  
Vol 107 (12) ◽  
pp. 1791-1799 ◽  
Author(s):  
Takuji Okusaka ◽  
Taiga Otsuka ◽  
Hideki Ueno ◽  
Shuichi Mitsunaga ◽  
Rie Sugimoto ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase I ◽  
Phase I Study ◽  
Japanese Patients ◽  
Advanced Hepatocellular Carcinoma ◽  
Liver Impairment

scholarly journals Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

2013 ◽  
Vol 32 (2) ◽  
pp. 388-388
Author(s):  
Yu Sunakawa ◽  
Junji Furuse ◽  
Takuji Okusaka ◽  
Masafumi Ikeda ◽  
Fumio Nagashima ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients

A phase I study of resminostat in Japanese patients with advanced solid tumors

2015 ◽  
Vol 75 (6) ◽  
pp. 1155-1161 ◽  
Author(s):  
Satoru Kitazono ◽  
Yutaka Fujiwara ◽  
Shinji Nakamichi ◽  
Hidenori Mizugaki ◽  
Hiroshi Nokihara ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients ◽  
Advanced Solid Tumors

scholarly journals A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors

2016 ◽  
Vol 79 (1) ◽  
pp. 89-98 ◽  
Author(s):  
Toshihiko Doi ◽  
Nozomu Fuse ◽  
Takayuki Yoshino ◽  
Takashi Kojima ◽  
Hideaki Bando ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients ◽  
Pi3k Inhibitor

Abstract A167: A phase I study of single-agent BEZ235 (SDS sachet), once- or twice-daily, in Japanese patients with advanced solid tumors.

2013 ◽  
Author(s):  
Koichiro Watanabe ◽  
Hironobu Minami ◽  
Satoshi Otsu ◽  
Yoshinori Hirashima ◽  
Ryotaro Morinaga ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Single Agent ◽  
Japanese Patients ◽  
Advanced Solid Tumors

scholarly journals A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumors

2019 ◽  
Vol 37 (5) ◽  
pp. 1061-1074 ◽  
Author(s):  
Toshihiko Doi ◽  
Takeshi Aramaki ◽  
Hirofumi Yasui ◽  
Kei Muro ◽  
Masafumi Ikeda ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients ◽  
Humanized Monoclonal Antibody ◽  
Antibody Targeting

scholarly journals Phase I study of sorafenib in Japanese patients with hepatocellular carcinoma

2007 ◽  
Vol 0 (0) ◽  
pp. 071113200242005-??? ◽  
Author(s):  
Junji Furuse ◽  
Hiroshi Ishii ◽  
Kohei Nakachi ◽  
Eiichiro Suzuki ◽  
Satoshi Shimizu ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase I ◽  
Phase I Study ◽  
Japanese Patients
Sign in / Sign up

Export Citation Format

Share Document